Neuroone Medical Technologies (NMTC) FCF Margin (2010 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly FCF Margin came in at 55.82% in Q2 2026, up 3303.0% on a YoY basis from 1.64% in Q2 2025, and up 23.97% quarter-over-quarter from 73.43% in Q1 2026.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) FCF Margin (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported FCF Margin for 13 consecutive years, with 55.82% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin rose 3303.0% year-over-year to 55.82%; the trailing twelve-month figure through Jun 2026 stood at 75.63% (down 1399.0% YoY), and the FY2025 full-year result was 32.09%, up 29030.0% from the prior year.
- FCF Margin rose to 55.82% in Q2 2026 per NMTC's latest filing, from 73.43% in the prior quarter.
- Across five years, FCF Margin topped out at 1383.43% in Q3 2022 and bottomed at 9061.09% in Q1 2022.
- Historically, FCF Margin has averaged 1279.75% across 5 years, with a median of 223.92% in 2024.
- The sharpest annual moves came in 2022 and 2023: FCF Margin plunged 261163 bps in 2022, then surged 826156 bps in 2023.
- Over 5 years, FCF Margin stood at 3057.95% in 2022, then soared by 87 bps to 393.45% in 2023, then soared by 101 bps to 5.61% in 2024, then tumbled by 2046 bps to 109.13% in 2025, then soared by 49 bps to 55.82% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 55.82%, 73.43%, and 109.13% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.73% |
| 10 | Neuroone Medical Technologies | 14.33 Mn | 12.29 Mn | 1.18 Mn | -55.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.82% |
| Mar 31, 2026 | -73.43% |
| Dec 31, 2025 | -109.13% |
| Sep 30, 2025 | -56.05% |
| Jun 30, 2025 | -88.86% |
| Mar 31, 2025 | -4.28% |
| Dec 31, 2024 | 5.61% |
| Sep 30, 2024 | -993.00% |
| Jun 30, 2024 | -287.63% |
| Mar 31, 2024 | -160.21% |
| Dec 31, 2023 | -393.45% |
| Sep 30, 2023 | -399.10% |
| Jun 30, 2023 | -488.89% |
| Mar 31, 2023 | -799.53% |
| Dec 31, 2022 | -3,057.95% |
| Sep 30, 2022 | 1,383.43% |
| Jun 30, 2022 | -8,396.07% |
| Mar 31, 2022 | -9,061.09% |
| Dec 31, 2021 | -8,120.86% |
| Sep 30, 2021 | -4,270.97% |